Drug interactions
Octreotide + Umeclidinium bromide / vilanterol inhaled
Severity: Minor
Octreotide and Umeclidinium bromide / vilanterol inhaled: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Vilanterol, a long-acting beta agonist, can prolong QTc and raise heart rate. Octreotide may add conduction effects, though inhaled systemic exposure is low at usual doses.
What this interaction means in plain words
Octreotide and Umeclidinium bromide / vilanterol inhaled have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible additive QT effects; vilanterol beta-agonist cardiac stimulation with octreotide-related conduction changes.
What to do
No routine change is needed. Monitor heart rate and ECG in patients with existing QT risk factors or cardiac disease.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Umeclidinium bromide / vilanterol inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Octreotide
Frequently asked questions
Can I take Octreotide with Umeclidinium bromide / vilanterol inhaled?
MediHelp rates the interaction as minor. Octreotide and Umeclidinium bromide / vilanterol inhaled have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vilanterol, a long-acting beta agonist, can prolong QTc and raise heart rate. Octreotide may add conduction effects, though inhaled systemic exposure is low at usual doses.
How serious is the interaction between Octreotide and Umeclidinium bromide / vilanterol inhaled?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Monitor heart rate and ECG in patients with existing QT risk factors or cardiac disease.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
